Back

Risk of Suicide Attempts and Self-Directed Violence after SARS-CoV-2 Infection: Outcomes from an Emulated Trial of a Nationwide Observational Matched Cohort of US Veterans

Hynes, D. M.; Niederhausen, M.; Chen, J.; Shahoumian, T.; Rowneki, M.; Hickok, A.; Shepherd-Banigan, M.; Hawkins, E. J.; Naylor, J.; Teo, A. R.; Govier, D. J.; Berry, K.; McCready, H. D.; Osborne, T. F.; Wong, E. S.; Hebert, P. L.; Smith, V. A.; Bowling, C. B.; Boyko, E. J.; Ioannou, G. N.; Iwashyna, T. J.; Maciejewski, M. L.; O'Hare, A. M.; Viglianti, E. M.; Bohnert, A.

2022-12-26 infectious diseases
10.1101/2022.12.23.22283902 medRxiv
Show abstract

ImportanceThe negative health-related effects of SARS-CoV-2 infection may include increased risk for self-directed violence. ObjectiveTo assess suicide attempts and other self-directed violence risk among US Veterans with a positive polymerase chain reaction (PCR) test for SARS-CoV-2 infection compared to matched uninfected Veterans. Design, Setting, and ParticipantsUsing a target trial emulation design supported by comprehensive electronic health records from the US Veterans Health Administration, Veterans who had a positive PCR test between March 1, 2020 and March 31, 2021 were matched with non-infected comparators. Monthly matching was anchored to first positive PCR test for each patient. Groups were followed for one-year thereafter. ExposurePositive SARS-CoV-2 PCR. Main Outcomes and MeasuresSuicide attempts and self-directed violence documented in electronic health records by a VHA provider. Hazard ratios (HR) for time to first suicide attempt and self-directed violence (separate models) for the infected versus comparator group were measured using Cox regression models. Analyses were performed for short-term (days 1-30), long-term (days 31-365) and one-year (days 1-365) and further stratified by age and prior self-directed-violence history. Sensitivity analyses included censoring to address comparators crossing over by later testing positive for SARS-CoV-2. ResultsAmong the 1,190,974 Veterans included, during the one-year period after the index date; 3,078 (0.258%) had a suicide attempt and 2,887 (0.242%) had self-directed violence. Regardless of follow-up duration, the HRs for suicide attempts and self-directed violence were higher for the infected group. For suicide attempts, short-term HR=2.54 (95% Confidence Interval [CI]: 2.05 to 3.15), long-term HR=1.30 (CI: 1.19 to 1.43) and one-year HR= 1.41 (CI: 1.30, 1.54). For self-directed violence, short-term HR=1.94 (CI: 1.51 to 2.49), long-term HR=1.32 (CI: 1.20 to 1.45), and one-year HR=1.38 (CI:1.26, 1.51). Conclusions and RelevanceIn matched cohorts, Veterans who had a positive SARS-CoV-2 PCR test had a higher risk of suicide attempt and self-directed violence that were greatest within the first 30 days and present for at least one year following. These findings highlight the importance of assessing patient experiences of suicide attempt and other forms of self-directed violence during different time periods post-infection to identify opportunities to augment prevention efforts and support those affected. Trial RegistrationNot applicable Key PointsO_ST_ABSQuestionC_ST_ABSWhat were the risks of suicide attempts and self-directed violence among US Veterans with SARS-CoV-2 infection compared to a matched cohort? FindingsIn this target trial emulation study of a nationwide observational cohort of 1,190,974 matched US Veterans in the Veterans Health Administration from 3/1/2020-3/31/2021, those with a confirmed PCR test for SARS-CoV-2 infection had increased risk of both suicide attempts and self-directed violence that was greatest within 30 days after infection and persisted over the following year. Over the year, those in the infected group had 1.40 times risk of a suicide attempt and 1.38 times risk of experiencing self-directed violence versus those in the comparison group. MeaningCOVID-19 survivors may require additional screening and prevention resources for suicide attempts and other forms of self-directed violence.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Annals of Internal Medicine
27 papers in training set
Top 0.1%
17.4%
2
PLOS Medicine
98 papers in training set
Top 0.1%
17.4%
3
JAMA Network Open
127 papers in training set
Top 0.1%
10.3%
4
Clinical Infectious Diseases
231 papers in training set
Top 0.5%
9.1%
50% of probability mass above
5
PLOS ONE
4510 papers in training set
Top 25%
6.8%
6
BMJ Open
554 papers in training set
Top 5%
3.9%
7
American Journal of Epidemiology
57 papers in training set
Top 0.5%
2.1%
8
The British Journal of Psychiatry
21 papers in training set
Top 0.4%
1.9%
9
The Lancet Infectious Diseases
71 papers in training set
Top 2%
1.7%
10
Nature Communications
4913 papers in training set
Top 57%
1.2%
11
eClinicalMedicine
55 papers in training set
Top 1%
1.2%
12
International Journal of Environmental Research and Public Health
124 papers in training set
Top 6%
0.9%
13
JMIR Public Health and Surveillance
45 papers in training set
Top 3%
0.9%
14
American Journal of Preventive Medicine
11 papers in training set
Top 0.4%
0.9%
15
Scientific Reports
3102 papers in training set
Top 73%
0.8%
16
JMIRx Med
31 papers in training set
Top 2%
0.7%
17
Journal of General Internal Medicine
20 papers in training set
Top 1%
0.7%
18
BMC Medical Research Methodology
43 papers in training set
Top 1%
0.7%
19
Occupational and Environmental Medicine
15 papers in training set
Top 0.2%
0.7%
20
Emerging Infectious Diseases
103 papers in training set
Top 3%
0.7%
21
Translational Psychiatry
219 papers in training set
Top 4%
0.7%
22
EClinicalMedicine
21 papers in training set
Top 1%
0.7%
23
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.7%
24
BMJ
49 papers in training set
Top 1%
0.7%
25
Frontiers in Medicine
113 papers in training set
Top 7%
0.7%
26
Psychiatry Research
35 papers in training set
Top 2%
0.6%
27
BMC Public Health
147 papers in training set
Top 6%
0.6%
28
BMC Medicine
163 papers in training set
Top 8%
0.6%
29
Clinical Microbiology and Infection
60 papers in training set
Top 2%
0.6%
30
The Lancet
16 papers in training set
Top 0.9%
0.6%